Locations:

Research

18-NEU-547-Uchino-Medicare-Stroke-650×450

January 24, 2018/Neurosciences/Research

Stroke Deaths Plummet as IV Thrombolytic Therapy Surges, Medicare Database Study Finds

One-year stroke mortality rate down by 18 percent over five years

January 15, 2018/Cancer

Survival Benefit of Adjunctive Tumor-Treating Fields Therapy Confirmed in Glioblastoma

First new medical intervention in a decade to demonstrate improved survival

December 18, 2017/Neurosciences/Research

Deep Brain Stimulation of the Ventral Striatal Area for Post-Stroke Pain Syndrome: An MEG Study

Does the clinical benefit manifest electrophysiologically?

December 7, 2017/Neurosciences/Research

Functional and Structural Brain Connectivity in Prodromal Huntington’s Disease

Advances toward biomarkers of progression are underway

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 2, 2017/Neurosciences/Research

Treating Sleep Apnea Improves Long-Term Seizure Control in People with Epilepsy

Mounting evidence of PAP therapy’s benefits in largest series to date

November 17, 2017/Cancer

Cleveland Multiport Catheter Enhances Topotecan Delivery in High-Grade Glioma

Report from first-in-human study of new convection-enhanced delivery device

October 31, 2017/Neurosciences/Research

SPRINT-MS: Ibudilast Shows Unprecedented Slowing of Brain Atrophy in Progressive MS

Paves way for phase 3 testing of novel treatment approach

October 26, 2017/Cancer

Can Angiogenesis Unlock Mysteries of Glioblastoma? A Report from 3 Investigative Fronts

Research momentum promises implications for tumors beyond the brain

17-NEU-4135-Hersh-Ontaneda-MS-MRI-650×450

October 25, 2017/Neurosciences/Research

Observational Studies in MS Therapeutics: Harnessing Insights from Real-World Data

Addressing clinically relevant questions that RCTs can’t touch

October 18, 2017/Neurosciences/Research

First Trial of DBS for Stroke Recovery: Initial Patient’s Functional Progress Continues Through 5 Months

A trial status update and overview of investigational aspects

BackPage 14 of 21Next